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Background – The energetics of cerebral activity critically relies on the functional and metabolic interac-
tions between neurons and astrocytes. Important open questions include the relation between neuronal versus
astrocytic energy demand, glucose uptake and intercellular lactate transfer, as well as their dependence on the
level of activity.
Results – We have developed a large-scale, constraint-based network model of the metabolic partnership
between astrocytes and glutamatergic neurons that allows for a quantitative appraisal of the extent to which
stoichiometry alone drives the energetics of the system. We find that the velocity of the glutamate-glutamine
cycle (Vcyc) explains part of the uncoupling between glucose and oxygen utilization at increasing Vcyc levels.
Thus, we are able to characterize different activation states in terms of the tissue oxygen-glucose index (OGI).
Calculations show that glucose is taken up and metabolized according to cellular energy requirements, and that
partitioning of the sugar between different cell types is not significantly affected by Vcyc. Furthermore, both the
direction and magnitude of the lactate shuttle between neurons and astrocytes turn out to depend on the relative
cell glucose uptake while being roughly independent of Vcyc.
Conclusions – These findings suggest that, in absence of ad hoc activity-related constraints on neuronal and
astrocytic metabolism, the glutamate-glutamine cycle does not control the relative energy demand of neurons
and astrocytes, and hence their glucose uptake and lactate exchange.
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I. BACKGROUND
Sustained cerebral activity is crucially dependent on the
functional and metabolic interplay of neurons and glial cells.
Spectroscopic and imaging methods have indeed shown that
the brain accommodates a wealth of cell-to-cell interactions,
which ultimately have contributed to displace the decades-
old notion that merely coupled whole brain activity to neu-
ronal glucose oxidation (for a comprehensive review, see [1]).
In particular, carbohydrate metabolism is compartmentalized
among neurons and astrocytes, which, together with the in-
terstitial space, represent nearly 90% of the tissue. Although
there is evidence for the trafficking of metabolic intermedi-
ates between the two cell types, its significance and depen-
dence on the activation state are not fully elucidated. More
than 15 years ago it was hypothesized that astrocytes may
support the energetics of brain function by the provision of
glucose-derived lactate to neurons, in an activity-dependent
manner [2]. However, the idea of a metabolically signifi-
cant astrocyte-to-neuron lactate shuttle (ANLS), as well as the
activity-dependent increase in astrocytic glucose uptake, has
proven to be rather difficult to confirm in vivo, while indirect
and not always reproducible experimental proof was mainly
obtained from experiments on cell cultures (see [3, 4] and the
excellent reviews [5, 6]).
The difficult interpretation and integration of the experi-
mental findings produced a substantial theoretical effort aimed
∗Authors contributed equally.
at characterizing intra- and inter-cellular metabolic fluxes [7–
12]. So far, mathematical models of transport and metabolism
of glucose in neurons and astrocytes using either kinetic [7, 9–
11] or stoichiometry-based [13–15] approaches have provided
conflicting results about the relevance of the cell-to-cell lac-
tate shuttle (CCLS) (see [16] for a recent review). This, in
turn, raised some debate, especially concerning the partition-
ing of glucose between neurons and astrocytes and the poten-
tially resulting intercellular lactate flow [17]. A recent flux-
balance-analysis (FBA) study indicates that the direction and
magnitude of the CCLS between neurons and astrocytes de-
pends critically on the relative uptake of blood-borne glucose
[18]. The sharing of glucose between the two cell types is
itself governed by the internal energetic demand of cells, im-
plying that glucose partitioning alone cannot be used to draw
any conclusion on the functional variations of the CCLS [11].
A critical reassessment of previous modeling results suggests
that the CCLS might remain of minor significance in terms of
transferred carbon equivalents [19].
On the other hand, the known regulations of enzyme-
catalyzed reactions implemented in dynamical models have
so far proved insufficient to justify a fundamental energetic
role for the CCLS [11]. In particular, the differences between
metabolic pathways of neuronal and astrocytic networks do
not imply the occurrence of lactate exchange between cells,
most likely because neurons and astrocytes do possess a rel-
atively high self-sufficiency for both glycolytic and oxidative
glucose metabolism (see [20] and references therein). This
means that lactate is oxidatively metabolized in the same com-
partment where it is produced by glycolytic processing of glu-
cose.
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2The aim of this study is to examine the activity-dependent
metabolic cooperation of glutamatergic neurons and astro-
cytes from a network-based perspective. Specifically, two is-
sues lie at the core of our work: (i) the correlation between
partitioning of glucose and lactate shuttling; and (ii) their
functional modulation across varying levels of glutamate-
glutamine cycle. We have employed a constraint-based setting
where an extensive and controlled sampling of the solution
space is possible [19, 21] on a large-scale model of compart-
mentalized brain energy metabolism. At odds with previous
studies employing constraint-based schemes to analyze the
neuron-glia system in specific conditions (different from those
considered here, see [23]), our approach does not rely on an
objective function (which in our case would be hard to design)
to define the relevant states. In addition, it allows to analyze in
detail the feasible metabolic states for networks whose sizes
are beyond those covered by other approaches like Bayesian
Flux Balance Analysis (BFBA) [15] or Montecarlo sampling
of mass-balance equations [24]. Finally, we have not made
any special assumption on the regulation of biochemical path-
ways with respect to the activation level, nor have we imposed
specific constraints on transport fluxes (except for the uptake
of glucose that we use to fine-tune the oxygen-to-glucose in-
dex (OGI), see below). In short, we show that, within our
stoichiometric approach:
(a) the OGI is able to distinguish states characterized by
different levels of neurotransmission, as flux configurations
with larger OGIs typically carry smaller values for the velocity
of the glutamate-glutamine cycle;
(b) the partitioning of glucose between neurons and astro-
cytes is roughly independent of the level of activity;
(c) the magnitude and direction of the CCLS depend
strongly on glucose partitioning while being roughly indepen-
dent of the level of neurotransmission.
In other terms, within a purely stoichiometric model, the
system’s energetics is determined to a significant extent by the
sharing of glucose. These results support the idea that neuro-
transmission does not impose significant constraints on glu-
cose partitioning or CCLS. In addition, we show that (d) the
overall degree of correlation among metabolic reaction fluxes
between and within cells changes drastically in the presence
of neurotransmission, pointing to an extended metabolic and
possibly functional partnership between neurons and astro-
cytes.
II. METHODS
A. Network reconstruction
The reaction network we considered (a reduced sketch of
which is given in Figure 1) is composed of four main com-
partments: neuron (n), astrocyte (a), extracellular space (e)
and blood capillary (c). Within the neuronal and astrocytic
elements we also distinguished the cytosol (nc and ac, respec-
tively), mitochondria (nm and am) and synaptic vesicles (nv,
only in neurons). Transport of nutrients from the blood to the
brain parenchyma is provided by the capillary. We assumed
that under resting conditions glucose and oxygen irreversibly
enter the brain, while lactate is not significantly exchanged
[25, 26]. Specifically, glucose can be taken up directly by as-
trocytes via the basal lamina or can diffuse into the extracellu-
lar space [9]. The latter, in turn, is a common compartment for
glucose uptake by neurons and astrocytes, as well as for lac-
tate shuttling between the two cell types. Oxygen can freely
diffuse from the capillary to cells. We lumped together the en-
dothelium and basal lamina with the capillary compartment,
which also means that we assume a negligible metabolism for
endothelial cells.
The neuronal and astrocytic compartments are equipped
with the enzymatic machinery to carry out the main path-
ways of carbohydrate metabolism (glycolysis, pentose phos-
phate shunt, TCA cycle, oxidative phosphorylation) [27].
Both cell types indirectly transport reducing equivalents (i.e.
NADH) from cytosol to mitochondria via malate-aspartate
shuttle (MAS) (see [28]). We made the simplifying assump-
tion that only astrocytes are capable of glutathione synthesis
because neurons, unlike astrocytes, are unable to efficiently
transport cystine [29] and, importantly, they cannot increase
the substrate flow through glutamate-cystine ligase [30], the
rate limiting step in glutathione synthesis. Yet, the antioxi-
dant system is equally present in neurons and astrocytes to
detoxify the reactive oxygen species (ROS) produced by ox-
idative phosphorylation. The stoichiometry of ROS produc-
tion by oxidative phosphorylation was chosen assuming that
5% to 15% of glucose is processed through the pentose phos-
phate pathway to regenerate the NADPH required for reduc-
ing oxidized glutathione [29, 30]. Anaplerosis of TCA cycle
intermediates is performed by pyruvate carboxylation, which
is confined to astrocytes [31], as well as by the activity of the
neuronal and astrocytic malic enzyme [32].
The functional portion of the metabolic network includes
glutamatergic neurotransmission, transmitter recycling and
ionic movements, that together establish the coupling be-
tween activity and metabolism through the action of the Na/K-
ATPase [33]. Specifically, the glutamate stored in neuronal
synaptic vesicles can be released in the extracellular space,
from where it is taken up by astrocytes in co-transport with
three Na+ ions and counter-transport of one K+ ion. Gluta-
mate is amidated to glutamine by astrocytic glutamine syn-
thetase (GS) with the concurrent hydrolysis of one molecule
of ATP. Glutamine is then exported to neurons where it is
eventually converted back to glutamate and loaded into synap-
tic vesicles again, which costs another ATP. Astrocytic uptake
of glutamate and release of glutamine, together with neuronal
uptake of glutamine and release of glutamate configure the
so-called glutamate-glutamine cycle. In this way, the clear-
ance of neuronally released glutamate from the extracellular
space is mostly accomplished by astrocytes [34], although
a fraction of the neurotransmitter can be taken up by neu-
rons, especially in synapses not associated with astrocytic
processes [35]. At odds with previous mass-balance model-
ing works [15, 17, 18], we included the ionic currents related
to membrane depolarization, albeit these were not explicitly
linked to glutamate release. In particular, neurons possess
Na+ and K+ channels that mimic voltage-gated ion chan-
nels and astrocytes can also take up potassium from the ex-
tracellular space with the Na-K cotransporter. Overall, the
fluxes of Na+ and K+ activate Na/K-ATPase, which con-
sumes one ATP to transport three Na+ out of the cell and
two K+ inside the cell. Importantly, not all the glutamate
which is taken up by astrocytes is channeled via the glutamate-
3FIG. 1: Schematics of the model – The figure shows selected pathways linking the four compartments of the model (capillary, interstitium or
extracellular space, neuron, astrocyte). Nutrients from the blood capillary have to traverse endothelium and basal lamina (these elements have
been lumped together with the capillary) to enter the brain parenchyma. Thus, arrows connecting directly capillary and cell interior represent
flows across basal lamina after endothelium. Note that this shortcut makes sense for the diffusion of oxygen to neurons and astrocytes, as
well as for the transport of glucose to the astrocytic compartment only. Indeed, astrocytes but not neurons are in close apposition to cerebral
blood vessels. Most of the nutrients delivery to the brain occurs through interstitial space, which is therefore the primary common element
for intercellular metabolite trafficking. Once into the cells, glucose (GLC) is metabolized via glycolysis to pyruvate (PYR), which can be
either reduced to lactate (LAC) or further oxidized in the cell TCA cycle requiring oxygen (O2). Neuronal glutamate (GLU) is sequestered by
the TCA cycle at the level of alpha-ketoglutarate (AKG) and loaded into synaptic vesicles (not shown). Neurotranmission evokes the release
of vesicular glutamate into the extracellular space, from where it is taken up by astrocytes and mixed with their glutamate pool. Astrocytic
glutamate can either be converted to glutamine (GLN) for export to neurons or enter the TCA cycle. The entire process consumes energy
due to up-regulation of astrocytic Na+/K+-ATPase and glutamine synthetase (Vcyc), as well as neuronal vesicle (re)filling. According to
the minimal-constraints strategy employed in the present model, ionic fluxes in neurons via ligand- and voltage-gated ion channels and in
astrocytes via Na+/K+ cotransporter follows neurotransmission passively (see text). See the Supporting Information for the full details of the
network structure (139 reactions among 108 different chemical species).
glutamine cycle. Glutamate in astrocytes can be used for
energy production by entering the TCA cycle after conver-
sion to alpha-ketoglutarate through transamination by aspar-
tate aminotransferase (AAT) or dehydrogenation by glutamate
dehydrogenase (GDH) [36]. We did not include the action
of other transaminase, e.g. alanine aminotransferase. This
choice precludes testing the exchange of lactate and of ala-
nine between neurons and astrocytes for maintaining ammo-
nia homeostasis during glutamate-glutamine cycle [37]. How-
ever, the role of this shuttle was experimentally found to be
activity-independent in neuronal-astrocytic cultures [38]. Fi-
nally, we conformed to other mass-balance modeling works
[15, 17] in excluding the pathways involved in the synthesis
and degradation of nucleic and amino acids. This is justified
by the different characteristic time-scales of processes under-
lying energy metabolism and gene expression, and does not
rule out the possibility of any change in flux velocity brought
about by e.g. protein translocation.
The network altogether consists of 139 reactions processing
108 different chemical species. The full lists of reactions and
chemical species is reported in the Supporting Text.
4B. Flux model
We assume that the reaction network described above oper-
ates at stationarity, i.e. that reaction fluxes in feasible configu-
rations are constant. More precisely, we postulate that the sys-
tem is kept in a non-equilibrium steady-state (NESS) by the
boundary conditions (in our case, by the fluxes of glucose and
oxygen into the capillary). Although a steady-state approach
for cerebral metabolism will clearly be unable to capture tran-
sient or kinetic effects, it can be justified by several consid-
erations. In first place, a typical experiment is performed on
tissue volumes containing a large number of cells, and a stan-
dard outcome will roughly represent an average over cells in
the entire sample. Such averaging can be reasonably approx-
imated with a steady–state assumption, provided the environ-
mental conditions, including stimulation and activation, are
stationary. This excludes from the analysis the time intervals
associated to the transitions from one state to another (e.g.
stimulation onset), which commonly last for a few tenths of
a second before a steady–state is attained [39]. Related to
this is the fact that in many cases the duration of a stimulus
largely exceeds the equilibration time of metabolite concen-
trations. It has indeed been shown that sustained stimulation
induces, after a short transient, a switch to different stationary
states for metabolism, neuronal activity, and hemodynamic re-
sponses [39–41]. Essentially, the steady-state approach allows
for the study of brain metabolism on a time scale lying be-
tween the fast adaptation to the change in the activation con-
dition and the slow adjustment of regulatory mechanisms. Fi-
nally, within this approach it is possible to treat systems much
larger than those accessible to kinetic modeling (see for exam-
ple [23]), where only a few nodes of the metabolic networks
are usually included.
Constraint-based models provide a standard framework for
the analysis of biochemical networks in NESS. In Flux-
Balance Analysis (FBA), for instance, one imposes that the
vector of concentrations of intracellular metabolites c, which
in general would vary in time according to
c˙ = Sν − b , (1)
(where S denotes the M ×N stoichiometric matrix, N is the
number of reactions, M that of metabolites, ν the vector of
reaction fluxes, and b the vector of in- and out-takes that gov-
ern the transport of chemical species to and from the system)
is constant. In turn, fluxes need to adjust to satisfy simple
mass-balance conditions for the individual chemical species,
amounting to the set of M equations
Sν = b . (2)
Note that the elements of b are non-zero only for metabolites
that are exchanged with the environment. For sakes of defi-
niteness, bounds of variability for each flux νi (i = 1, . . . , N )
need to be specified. Usually, such bounds account for re-
versibility assignment, i.e. they are either of the form −∞ <
νi < ∞ (for reversible reactions) or of the form 0 ≤ νi < ∞
(for irreversible reactions), although in some cases physio-
logical considerations may lead to consider more complicated
cases, e.g. ν0 ≤ νi < ∞ with ν0 > 0. (In the present study,
we shall only consider bounds for the putative reversibility of
reactions, as detailed in the network reconstruction reported
in the Supporting Text, except for the glucose uptake flux to
the capillary which is taken to be fixed. See below for details.)
The system (2) now defines a solution space as a polytope
of dimension N −M (or more precisely, N − rank(S); note
that, typically, N > M ). In the absence of a refinement cri-
terion, like an ad hoc optimization prescription (see e.g. [42]
for an excellent introduction to this modeling perspective), the
set of solutions should ideally be sampled uniformly to extract
both the individual solutions as well as the statistics of fluxes
(averages, correlations, etc.). This is indeed the type of infor-
mation we are interested in retrieving in the present case. Un-
luckily, exact sampling algorithms (e.g. Monte Carlo) are still
inapplicable to genome-scale flux models when the dimension
of the solution space exceeds a few tens because of their high
computational costs [43]. (See however [10] for a promising
set of alternative techniques.) In addition, the straightforward
application of FBA-type of constraints in the our case is also
made difficult by the fact that our reconstruction is largely in-
complete. This means that the pathways we do not include
may have a considerable cross-talk with the core carbon path-
ways on which we focus, so that the solutions of (2) might
depend strongly on the choice of the boundary fluxes that rep-
resent the interaction between pathways included in the recon-
struction and the rest of the metabolic network.
We therefore took a step back with respect to FBA and con-
sidered a broader type of conditions, inspired by Von Neu-
mann’s model of production networks [45]. In essence we
simply replace (2) with
Sν ≥ 0 (3)
for all intracellular metabolites, while keeping (2) for in-takes
(nutrients). Clearly, the main difference with (2) is that (3) al-
lows for flux vectors generating a net production of chemical
species (corresponding to the metabolites for which the strict
inequality holds in (3)). In a nutshell, the rationale behind this
is that a net production of certain compounds might be ex-
pected in cells if they need to be employed in macromolecular
processes (e.g. proteinogenesis) lying out of the domain of
metabolism or, more relevantly to our case, in portions of the
network that are not included in the reconstruction. (In other
terms, the presence of gaps and their impact on the flux orga-
nization of the core network may be smoothened out by soft-
ening the constraints.) Therefore, strictly speaking, a NESS
where the concentration of certain metabolites is formally in-
creasing in time (corresponding to the positive components of
the vector Sν) can be physiologically viable. Once the nutri-
ent availability is fixed through the boundary fluxes, the cell’s
metabolic production and nutrient usage profiles can be deter-
mined self-consistently from the solutions of (3).
The solutions of (2) and (3) will obviously coincide if all in-
equalities in (3) become equalities, though in general this does
not need to be the case. The main technical advantage of using
(3) lies in the existence of an effective and scalable relaxation
algorithm that allows to obtain a statistically controlled sam-
pling of its solution space in very modest CPU times. Such a
method has been defined in [46] and employed in e.g. [21] and
[19] to analyze the metabolic capabilities and the energy bal-
ance of the bacterium E. coli. The statistical properties of the
solution space sampling thus obtained are discussed in [19]
and further explained in the Supporting Text. In brief, the al-
gorithm makes use of a prior probability distribution of fluxes
5to initialize the flux variables and generates solutions such that
the average Euclidean distance between the solutions and the
prior is minimized, the average being carried out over initial
flux states sampled from the prior. A sufficiently unbiased
prior (e.g. a set of uncorrelated uniform distributions, as we
have employed here) then injects minimal a priori informa-
tion in the solution space and therefore provides a reasonably
unbiased, statistically controlled sampling of the feasible flux
states of the network. In turn, such an information allows to
extract physiological details of individual solutions, as well as
statistical properties of the solution space (e.g. probability dis-
tributions of fluxes and correlations). This is the calculation
scheme we have employed. Further details about the network
(i.e. the matrix S), the flux model and the algorithm used in
the present work are found in the Supporting Text.
In the following we shall denote the flux of an intracellular
reaction or of a transport process respectively by the acronym
of the corresponding enzyme or the name of the transported
metabolite. We shall also highlight the compartment in which
the reaction occurs (so that e.g. νPDH(n) will stand for the
pyruvate dehydrogenase–catalyzed reaction taking place in
the neuron) or the source/destination compartments that are
involved in a transport (for instance, νO2(c→ a) will denote
the transport of molecular oxygen from the capillary to the
astrocyte). Shorthands like νO2(→ c) will instead represent
the supply of metabolites (oxygen in this case) to the capil-
lary. Unless otherwise stated, fluxes are expressed in arbitrary
units and error bars correspond to one standard error.
III. RESULTS
A. Validation of the model: activation states
In the network model we consider, capillaries are supplied
with two compounds, namely glucose and oxygen, which can
then be transferred to the other compartments. We have char-
acterized the metabolic activity of the brain by fixing only the
uptake of glucose to the capillary, νGlc(→ c), while leaving
the oxygen influx free. In these conditions, each fixed value of
νGlc(→ c) generates a different solution space for (3), where
νO2(→ c) fluctuates across solutions (i.e., across feasible flux
configurations). This in turn yields, for each selected value of
νGlc(→ c), a distribution of values for the oxygen-glucose
index (OGI), defined as the ratio between cerebral metabolic
rates of oxygen (CMRO2 ) and glucose (CMRGlc). As both
nutrients do not accumulate in the tissue at steady-state, the
OGI can be defined as
OGI =
CMRO2
CMRGlc
=
νO2(→ c)
νGlc(→ c) . (4)
where nutrient influxes (both the numerator and the denomi-
nator) obey, as said above, mass-balance conditions:
νO2(→ c) = νO2(c→ a) + νO2(c→ n) (5)
νGlc(→ c) = νGlc(c→ a) + νGlc(c→ e) . (6)
Note that the last equation does not involve the neuronal com-
partment because glucose enters neurons via the extracellular
space only (as said before, the endothelium and basal lamina,
which mediate the transport of glucose to astrocytes and ex-
tracellular space, are included in the capillary compartment).
Note also that at steady-state one has
νGlc(c→ e) = νGlc(e→ a) + νGlc(e→ n) . (7)
Generically, larger OGIs imply larger fluxes through aero-
bic pathways, with OGI = 6 as the physiologic maximum
value for the steady state aerobic oxidation of glucose (cor-
responding to the fact that 6 oxygen molecules are required
to metabolize glucose to water and carbon dioxide). Never-
theless, OGI values larger than 6 are possible in cells when-
ever the carbon supply for cellular respiration exceeds glucose
processing through glycolysis (as happens, for instance, dur-
ing lactate uptake from the bloodstream). In the flux model
(3) it is possible to obtain OGI values slightly above 6, as a
consequence of the fact that the oxygen intake to the capil-
lary is a free variable, not bounded (within the model) by the
condition OGI ≤ 6. From a modeling viewpoint, this may
correspond to a small accumulation of intracellular oxygen
due to e.g. the absence of some oxygen-consuming pathways
in the network (this condition might not have a physiological
counterpart). Experimental in vivo measurements show that
the OGI decreases with increasing cerebral activation, from
values around 5.5 (almost complete glucose oxidation) under
awake resting conditions to values generally ranging from 4 to
slightly above 5 during focal brain activity, depending for ex-
ample on the stimulation paradigm, on the involved brain area,
on the experimental procedure (reviewed in [47, 48]). Since
the contribution of individual physiologic processes under dif-
ferent conditions is not known, we sought to model the level
of activation by using the OGI as a proxy. This assumption
stems from the notion that different metabolic states can be
characterized in term of their energy expenditure [49]. Fur-
thermore, the transition to a more glycolytic than oxidative
metabolism is thought to identify the transition from basal to
activated conditions [50]. These arguments suggests that brain
metabolism approaches full glucose oxidation as the overall
signaling activity decreases.
We have hence solved (3) for different values of νGlc(→ c)
recording the resulting OGI distributions. Figure 2 shows four
distributions of OGI corresponding to different glucose con-
sumption rates, starting from lower values of νGlc(→ c) cor-
responding to a larger average OGI. It should be noted that
there is not a clear consensus about the quantitative degree
of OGI decrease during activity. Indeed, while a value under
activation around 5.1 is suggested by several works [47, 48],
many others point towards lower values (see e.g. [51, 52] and
the recent [53]). Because of this, and because the OGI distri-
butions we found at a given νGlc(→ c) are rather broad, we
preferred to explore a relatively broad range of OGI values.
We have further characterized the model by monitoring the
degree of activation in terms of the velocity of the glutamine
synthetase (GS) catalyzed reaction. In our simulated network,
this univocally represents the rate of the so–called glutamate–
glutamine cycle Vcyc, or
Vcyc = νGS(a) . (8)
It should be noted that, in vivo, there is a residual rate of
Gln synthesis unrelated to neurotransmitters cycling [54],
but under physiological conditions νGS(a) ' Vcyc [55],
6FIG. 2: Computed probability distributions of oxygen-to-glucose
index (OGI) at different glucose uptakes – Top left to bottom right:
Uncoupling between glucose and oxygen utilization increases for in-
creasing overall glucose uptake (i.e. enhanced glutamatergic activ-
ity). The mean OGI decreases from 5.5 to 4.5 in correspondence of
an increased glucose consumption of about 15%. This behavior is in
a qualitative agreement with experimental evidence, and allows for a
definition of different activation states based on the uncoupling be-
tween glucose and oxygen consumption. Each OGI distribution thus
identifies a subset of solutions for subsequent flux analysis.
and thus we conformed to our general choice of neglect-
ing neurotransmission–unrelated amino acids synthesis also in
this specific case. The assumption that the residual rate of Gln
synthesis is independent of glutamatergic neurotransmission
is made also in the original experimental work that reported
Vcyc [54], and the relevant implications are discussed therein.
As happens for the OGI, each choice of νGlc(→ c) leads
to a distribution of values of Vcyc. Generically, solutions
with Vcyc = 0 (i.e. no neurotransmission [68]) will coex-
ist with solutions carrying a non-zero level of activation for
any choice of νGlc(→ c). In order to highlight the quanti-
tative changes induced by activation, we performed a corre-
lation analysis between the fluctuations of flow rates of reac-
tion or transport pathways, first in all the sampled solutions
(i.e. with Vcyc ≥ 0) and then in solutions with Vcyc > 0. It
turns out (see Figure 3) that the transition from uncostrained
neurotransmission to presence of neurotransmission has pro-
found consequences on the flux correlations within and be-
tween cells.
The solutions obtained for Vcyc > 0 underlie a substan-
tial increase of both the global and the regional correlation
level of the network. This is especially true for the corre-
lation between neuronal and astrocytic metabolism, confirm-
ing that the condition Vcyc > 0 identifies the functional and
metabolic partnership between the two cell types. This find-
ing shows that intercellular signaling has a major role for the
overall metabolic regulation at tissue level, constraining the
catabolism of each cell in a concerted range (see Discussion).
The above results suggest that, in order to capture the quan-
titative changes that occur in solutions at higher levels of ac-
tivation (recall that our model does not, per se, constrain the
magnitude of neurotransmission), it is useful to analyze the
behavior of the conditional average Vcyc versus the condi-
tional average OGI. In Figure 4 we display the results obtained
by retaining solutions with Vcyc ≥ 0 (i.e. all solutions, return-
ing the standard average) and Vcyc > 0, respectively.
One sees that as the average OGI decreases, the average
Vcyc increases to an enhanced activation level. The slope of
the curve is less negative for the condition Vcyc > 0, i.e. when
the sample is restricted by filtering–out the states with sup-
pressed neurotransmission. This changes the basal state at
OGI = 5.5 to a rate of glutamate-glutamine cycle larger by
about 30%, from 0.06 to 0.08 (roughly).
In summary, in agreement with the literature, we find that
the rise in anaerobic glucose consumption during activation
turns out to be out of proportion to oxygen utilization, as
evidenced by the decrease in the (average) OGI for increas-
ing values of Vcyc and CMRGlc . This indicates that the
glutamate-glutamine cycle by itself suffices to explain part
of the uncoupling between glucose and oxygen utilization.
It should be emphasized that the reported OGI reduction, al-
though potentially significant if caused by a specific subset of
glycolytically-served energetic demands, does not change the
overall strategy of brain energy metabolism, which remains
largely aerobic because of the higher ATP yield of respiration
[1].
B. Neuronal oxidative glucose metabolism versus
glutamatergic activity
The relationship between glutamate-glutamine cycle and
neuronal glucose oxidation was experimentally reported to be
close to a 1:1 relation [56]. In particular, the rate of neuronal
oxidative metabolism of glucose (i.e. the level of activity of
pyruvate dehydrogenase, PDH) increases linearly with the ve-
locity of transmitter cycling, with a slope close to one. Our
framework allows to address the dependence of glucose ox-
idation in neurons on the rate of glutamate-glutamine cycle
for various states of activation. Considering that PDH is the
primary entry point of glucose-derived pyruvate into the TCA
cycle, we define
CMRGlc(ox)(n) =
1
2
νPDH(n) , (9)
where the factor 1/2 is required as glycolysis produces two
molecules of pyruvate for each glucose molecule. Plotting
the average CMRGlc(ox)(n) against the average Vcyc we find
approximately two different regimes around the physiologic
range corresponding to OGI ' 5.5 (see Figure 5). These
regimes are characterized by almost linear relations, in agree-
ment with the experimentally reported constant stoichiometry
between aerobic Glc oxidation in neurons and glutamate cy-
cling [54, 56]. However, the coupling pattern changes as one
explores states with values of Vcyc departing from the basal
level to higher activity. The slope of the curve clearly in-
creases if only strictly positive Vcyc are considered, although
it stays below one. Interestingly, in the high Vcyc regime (up-
stream the awake value, for which no experimental data exist)
7FIG. 3: Pearson correlation coefficients for each pair of reactions – (a) Cycles, pathways and homogeneous reaction groups are reported
sideways, the compartment is reported at the bottom. Neuron and astrocyte sector also include transports from/to the cell, while the ex-
tra/intercellular class groups reactions that either directly connect neuron to astrocyte, or involve only extracellular compartments. Null fluxes
are represented in white. Above the diagonal we report the Pearson’s coefficients obtained by imposing Vcyc = 0, while below the diagonal
Vcyc is allowed to assume positive values. (b,c,d) Histograms of the Pearson correlation coefficients for each pair of reactions within neurons
(b), astrocytes (c) or between cells (d). For each plot, the distributions are reported for Vcyc = 0 (in pale blue) and Vcyc > 0 (transparent).
Null fluxes (i.e. those fluxes that are plotted in white in panel (a)) are excluded from the histograms. Apart of the apparent larger number of
null fluxes with Vcyc = 0, the histograms show that the bins at higher correlation tend to be more populated at Vcyc > 0 than at Vcyc = 0,
while the opposite holds for central bins (i.e. those bins with very low direct or inverse correlation).
the plot features a slight attenuation of the curve. The fact
that the slope is lower than the linear extrapolation at high ac-
tivity indicates that some source of energy consumption adds
to the glutamate–glutamine cycle during the transition from
normal to high neurotransmission levels. In this region, the
discrepancy between simulated and experimental data is ex-
plained by the relatively low increase in ionic fluxes through
neuronal voltage-gated Na+ and K+ channels obtained in our
simulations (data not shown), suggesting that the glutamate–
glutamine cycle alone is insufficient to account for the rise in
brain glucose utilization. To this end, it is mandatory for sto-
ichiometric models to incorporate energy use by action and
8FIG. 4: Computed average rate of the glutamate-glutamine cy-
cle versus average OGI – Simulations show that the average Vcyc
increases as the average OGI decreases, consistently with the un-
derlying relationship between OGI and glucose uptake. The curves
represent conditional averages, computed over solutions character-
ized respectively by Vcyc ≥ 0, and Vcyc > 0. The red dashed line
identifies the awake resting state (OGI = 5.5). The crossing points
between the line at OGI = 5.5 and each of the two curves identify the
values of Vcyc relevant for the basal conditions. Specifically, Vcyc is
roughly 0.06 or 0.08 for the groups Vcyc ≥ 0 and Vcyc > 0, respec-
tively. The two curves are significantly different for OGI & 4.75.
This is consistent with the fact that the contribution of solutions with
Vcyc = 0 becomes negligible at high activation levels.
synaptic potentials in addition to glutamatergic neurotrans-
mission.
C. Modulation of glucose uptake and cell-to-cell lactate
shuttling by glutamate-glutamine cycle
The fate of carbons undergoing oxidative phosphorylation
in neurons and astrocytes provides a quantitative hint of the
relative amount of energy produced by aerobic pathways in
the two cell types. We found that anaerobic and aerobic
metabolism is similarly increased in both cell types at increas-
ing activity (not shown). In particular, the fraction of cerebral
oxidative metabolism in astrocytes is about 35% of the total,
which is consistent with a substantial astrocytic contribution
to functional brain energy metabolism (reviewed in [57]).
Analysis of glucose fluxes showed large fluctuations, so
that both the neuron and the astrocyte may be the primary
sites of glucose consumption at fixed values of Glu/Gln cy-
cling. We indeed observed that both cell compartments can
absorb from 10% to 90% of the total glucose uptake respec-
tively. Therefore, at this level of detail, the network does not
place significant constraints on the cellular utilization of glu-
cose. The failure of up-regulation of ionic fluxes that we re-
port here might play a role if their contribution is substantially
different for neurons and astrocytes, which unfortunately has
not been yet experimentally determined.
FIG. 5: Rate of glucose oxidation in neurons as a function of the
Glu/Gln cycle – The curves represent conditional averages, com-
puted over solutions characterized respectively by Vcyc ≥ 0 and
Vcyc > 0. The dashed lines identify the awake resting state (OGI
= 5.5), corresponding to the group of solutions (Vcyc ≥ 0 and
Vcyc > 0) plotted with the same color. For the condition Vcyc > 0,
and possibly also for the condition Vcyc ≥ 0, the awake rest roughly
corresponds to a change of the line slope. Thus, the transition from
low to high activity is accompanied by a decreased energy consump-
tion relative to what would be extrapolated at low activity levels. In
particular, the slopes of the two curves at low Vcyc values are roughly
0.52 and 0.73 (for the groups Vcyc ≥ 0 and Vcyc > 0, respectively)
and decrease to roughly 0.28 and 0.33 at high Vcyc values, suggesting
a lack of energy demand at high activity (see text).
The direction of the shuttle of lactate depends in a robust
way on the sharing of glucose between neurons and astrocytes,
resulting in ANLS when the relative astrocytic glucose uptake
becomes larger than about 65% (implying that states support-
ing ANLS can be obtained by an ad hoc adjustment of Glc
partitioning) and NALS otherwise (Figure 6). As the latter is
also the mean value for the fraction of neuronal versus astro-
cytic oxygen utilization, it turns out that, on average, the con-
tribution of CCLS to cell metabolism is very low compared
to the lactate generated intracellularly by glucose. The strict
dependence of CCLS on cellular glucose uptake supports pre-
vious results obtained through various modeling approaches
[11, 18, 19].
A closer look at the individual solutions reveals the absence
of a significant correlation between the glutamate–glutamine
cycle and both the uptake of glucose and the shuttle of lactate
(Figure 7). It should however be stressed that, as can be seen
in Figure 7, the emerging scenario presents large fluctuations,
in the sense that, even within the physiological range for the
OGI, solutions with ANLS and NALS coexist. Together, these
simulation outcomes indicate that no preferential route is un-
dertaken by lactate at any given rate of glutamate-glutamine
cycle. Thus, the determinants for lactate accumulation and
shuttling, if any, must reside elsewhere, for example in the
balance between spiking and synaptic activity [58].
9FIG. 6: Intercellular lactate flow versus glucose partitioning be-
tween neuron and astrocyte – There is a clear dependence of the
CCLS on the cell glucose uptake. However, when partitioning of
glucose between neurons and astrocytes is around 65% (note that
CMRGlc(tot) = CMRGlc(a) + CMRGlc(n)), which also identifies
the concomitant fraction of oxygen utilization, the contribution of
transferred lactate is minimal. This means that he pyruvate derived
from CCLS is thus always much less than the pyruvate generated
by the concomitant uptake of glucose. Notably, if glucose is taken
up equally by the neuronal and astrocytic compartments, the di-
rection of lactate flow is preferentially from neurons to astrocytes
(νLAC(a → n) ' −0.3), contributing on average about 40% of
the total carbons metabolized by these cells (note that carbons from
lactate are obtained by considering the halved value of the flux).
FIG. 7: Net ANLS flux (left) and relative cell glucose uptake
(right) versus the velocity of the Glu/Gln cycle – Independently
of the correlation between νLAC(a → n) and glucose partitioning
observed in Fig. 5, neither variable shows significant correlation with
the activation level. This results from the absence of constraints im-
posed by stoichiometry on the rate of neurotransmission (hence on
the glutamate-glutamine cycle), the latter being compatible with a
large set of solutions relative to glucose partitioning and lactate shut-
tling.
D. Conserved moieties, transcellular aspartate shuttling and
glutathione-ascorbate cycle
To conclude, we discuss the flux organization of several
pathways that were included in the metabolic network recon-
struction, but whose involvement is not strictly related to lac-
tate trafficking. The ATP buffering systems of creatine and
adenylate kinase in neurons and astrocytes, as well as astro-
cytic glycogen metabolism were found to have negligible net
flux, consistently with the role of adenylates, creatine and
glycogen as conserved moieties in the steady-state. We are
unable to test hypotheses about the role of brain glycogen [59–
61], because our approach does not allow to describe the con-
sumption of previously stored metabolites, such as glycogen
in this case. We found that the contribution to NADH shut-
tling by the malate-aspartate shuttle (MAS) dominates over
the glycerol-3-phosphate pathway (relative flux is a few per-
cent). We could not support the recent hypothesis of a sig-
nificant steady state neuron-to-astrocyte transport of aspar-
tate [62]. However, this finding was expected due to the
presence of mitochondrial aspartate-glutamate carrier in as-
trocytes, which allows for a shunting pathway, alternative to
neuron-to-astrocyte aspartate transport that is sufficient to sus-
tain NADH shuttling from cytosol to mitochondria in astro-
cytes, as previously suggested [28]. In order to examine a pos-
sible role of (dehydro)ascorbate transfer between neurons and
astrocytes [63], we included the detoxification of reactive oxy-
gen species (ROS) via glutathione/ascorbate cycle. Unluckily,
we were unable to find statistically significant exchange fluxes
of the two forms of ascorbic acids between cells. This is pos-
sibly correlated with the fact that, as said above, we did not
include the entire network section associated with glutathione
synthesis. Theoretical analysis of transcellular ascorbate cy-
cling will thus require further refinements of the network re-
construction.
IV. DISCUSSION
This work is concerned with a model of brain energy
metabolism consisting of four compartments, representing
neuron, astrocyte, extracellular space and the capillary. We
used a steady state approach based on Von Neumann’s theoret-
ical framework for the analysis of production networks [45],
successfully applied to cellular metabolism in previous studies
[21]. The steady-state assumption for the metabolic coupling
between oxygen and glucose consumption underlying differ-
ent cortical states is consistent with (i) the fact that experi-
mental parameters have been measured under stationary con-
ditions during suppressed brain activity [54], and (ii) the es-
tablishment of a new metabolic steady-state during enhanced
brain activity [39]. At odds with standard schemes based
on flux-balance analysis though, the frame employed here
doesn’t constrain the net metabolite production to zero, but,
rather, aims at recovering the steady state self-consistently
from minimal stability requirements. The ‘soft’ type of con-
straints thus arising makes it possible to sample the solution
space corresponding to our large-scale network model in a sta-
tistically controlled manner, and returns a full range of feasi-
ble values for each reaction flux in the network, as well as
detailed information on correlations. Based on this, one can
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elucidate the extent to which stoichiometry alone constrains
the operation of brain metabolism, since the emerging picture
is obtained without imposing specific functional constraints.
First, we found that the rate of glutamate-glutamine cycle
distinguishes different activation states according to the frac-
tion of glucose that is processed via glycolysis versus respira-
tion. In particular, decreasing OGI values predict increasing
velocity of the cycle, and viceversa. Notably, ATP-consuming
Na+ and K+ fluxes across voltage- and ligand-gated ion chan-
nels are not directly dependent on glutamate-glutamine cy-
cle in our theoretical account. Pathways analysis showed that
their reaction rates do not “automatically” up-regulate along
with transmitter cycling. This indicates that the absence of
causal changes (i.e. constraints) in these different aspects of
neuronal signaling strongly underestimates the glucose uti-
lization at high activity levels. Unfortunately, it is presently
unknown how to model the exact cause-and-effect relation-
ship between glutamate-glutamine cycle and the ionic currents
that generated neurotransmission on one hand, and those that
are generated by neurotransmission on the other. The latter
will constitute a primary target of future studies.
Second, the results of the present model support previous
kinetic analyses indicating that lactate derived from astrocytes
may not provide an important source of carbon compounds for
neuronal energy metabolism in an activation-dependent man-
ner (Figure 6) [11]. The model also supports the conclusion
that the direction and magnitude of CCLS are secondary to
glucose partitioning between cell types [11, 19]. We found
that glucose uptake, glycolysis and respiration change propor-
tionally in a wide range of glutamate recycling rates. This
implies that the glucose taken up by each cell is completely
metabolized and not significantly converted to lactate. Thus,
lactate does not accumulate in a specific cell type, i.e. the lac-
tate concentration gradient, and hence lactate shuttle, remains
small.
Third, simulations showed that glutamate-glutamine cycle
is correlated with overall tissue glucose utilization and lactate
production, but not with specific patterns of cellular glucose
uptake and lactate shuttle (Figure 7). These results agree well
with the experimental knowledge [54, 64] and recover fea-
tures of different (and sometimes conflicting) numerical stud-
ies performed previously [17, 19]. Most importantly, they add
further arguments to the idea that the trafficking of molecules
between neurons and astrocytes underlies a broad functional,
rather than strictly energetic partnership (see, e.g. [65]). This
is evident in our modeling perspective, as possibly energy-
related changes in lactate fluxes are independent of concomi-
tant function-related variations in glutamate-glutamine cycle
(see Figure 7, that essentially shows a lack of correlation be-
tween lactate shuttling and transmitter cycling). Alternative
functions for lactate include the discrimination between dila-
tion and constriction of cerebral arterioles [66], or the mod-
ulation of GABAergic inhibitory activity of specific neuronal
populations [67]. These functional roles of lactate might be
still secondary to its accumulation in the tissue. Our simu-
lations suggest that this accumulation likely results from up-
regulation of non-oxidative metabolism in both neurons and
astrocytes, as previously suggested [11, 60].
We found that intercellular shuttling of lactate increases
only when glucose partitioning between neurons and astro-
cytes is significantly uneven (Figure 6). Therefore, lactate
transfer can be interpreted as a local biochemical shunt that
allows for the optimal use of carbon supply in correspon-
dence of variable environmental challenges. Interestingly, if
the functional partnership between neurons and astrocytes is
suppressed via the zeroing of neurotransmission, the anticor-
relation between glycolysis in the two cellular compartments
further increases (i.e. correlation becomes more negative), a
feature shared with many other fluxes related to energetics, in-
cluding TCA cycle and oxidative phosphorylation. So, even
when there is no functional relationship between neurons and
astrocytes, their energy (primarily glycolytic) metabolism is
anticorrelated. The reason for this behavior is that the two cell
types share the same environment, thereby the same glucose
availability. Glucose availability thus represents the primary
drive on glucose partitioning. If the two cells are functionally
independent, oxidative metabolism follows glycolysis, as also
evidenced by the negative correlation between neuronal and
astrocytic oxidative metabolism. As soon as neurons and as-
trocytes become coupled by neurotransmission, the network
shifts to correlated patterns of activity, both within the same
compartment and between different compartments. Accord-
ingly, glycolysis in one cell type becomes slightly positively
correlated with oxidative metabolism in the other. However,
glycolysis in either neurons or astrocytes, which essentially
reflect partitioning of tissue glucose, remains poorly corre-
lated with the glutamate-glutamine cycle. Overall, glutamate-
glutamine cycle positively correlates with cell TCA cycle and
oxidative phosphorylation much more than it does with gly-
colysis, which is especially significant for the astrocytic com-
partment.
In conclusion, we developed a large-scale model for com-
partmentalized brain energy metabolism including the core
carbon pathways of neurons and astrocytes, as well as further
compartments (capillary, extracellular space). A constraint-
based scheme was then employed in order to define feasi-
ble configurations of reaction fluxes. Our numerical analy-
sis was based on a relaxation algorithm which allows to ob-
tain a statistically controlled sampling of the solution space
without any prior assumption on the behaviour of energy pro-
ducing/consuming pathways. Results have shown that only
a large imbalance of cell glucose uptake can explain the oc-
currence of a significant lactate shuttle between neurons and
astrocytes, the latter being roughly independent of the rates
of transmitter cycling. Our results therefore do not support a
link between glutamate-glutamine cycle and CCLS as a mech-
anism for activation-dependent transfer of energy compounds
within the brain. On the other hand, CCLS can be found by
assuming that neurons have limited access to glucose and/or
by bounding their glucose uptake flux. The lack of correla-
tion we observe stems from the fact that the distribution of
activity-related energy stress between neurons and astrocytes
cannot be estimated by the stoichiometry of the metabolic net-
work and should be a primary target of current experimental
research. Future developments will focus on introducing min-
imal ad hoc constraints on neurotransmitter cycling and ionic
fluxes in the hope to capture the “non-stoichiometric” side of
the energetics of brain activity.
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SUPPORTING TEXT
Appendix A: Constraint-based flux model
The standard approach to modeling biochemical reaction
networks is based on enzyme kinetics and is normally formu-
lated through systems of differential equations for the time
evolution of the intracellular concentrations of metabolites,
like
c˙ = Sν − u (A1)
where c denotes the concentration vector, S the matrix of sto-
ichiometric indices, v the flux vector (in turn, a function of
concentrations, kinetic constants k, etc.: ν ≡ ν(c,k, . . .)),
and u the vector of uptakes describing the exchange of chem-
ical species with the environment. Limited knowledge of en-
zyme mechanisms and kinetic constants as well as the fast
increase in the number of parameters, however, effectively
circumscribes this framework’s applicability to small systems
(up to a few tens of reactions as in the case of human ery-
throcites [1]). Large- (possibly genome-) scale reaction net-
works require, to date, a different, simplified type of analysis.
Constraint based models are usually defined by the require-
ment that in non equilibrium steady states (NESS) the net rate
of change of the level of metabolites is zero (i.e. by homeosta-
sis). As a consequence, (A1) reduces to
Sν = u , (A2)
and one is interested in retrieving the flux patterns v that
are consistent with a NESS induced by the (given) vector
u of boundary fluxes [2–8]. In essence, constraint-based
models retain the information encoded in S as the key input
and use it to define, through (A2), a polytope of dimension
D = N−rank(S) (N being the number of reactions in the net-
work) that, if complemented with physiological bounds on the
flux variables and with detailed prescriptions for in- and out-
takes, can provide a sensible representation of the metabolic
capabilities of the cell in a given medium. In addition, they al-
low for the straightforward integration of biochemical, empir-
ical or thermodynamic data (when available) into the problem,
either as specific bounds on fluxes (e.g. for reaction direction-
ality) or in the form of extra constraints (e.g. conservation
laws). In the present study, each flux νi (i = 1, . . . , N ) is
assumed to be either irreversible, in which case its bound of
variability is simply 0 ≤ νi < ∞, or reversible, in which
case −∞ < νi < ∞. In the latter case, however, we in-
troduce two irreversible fluxes to describe the forward and
reverse processes respectively, so that, once every reversible
reaction is split in two, all bounds we consider are of the form
0 ≤ νi < ∞ (except for the glucose uptake flux to the cap-
illary which, as explained in the main text, is assumed to be
fixed.)
For many microbial metabolic networks S is known with
gene-level accuracy. In such cases, a characterization of the
cell’s metabolism can be obtained by sampling (ideally with
uniform probability) the space of feasible network configura-
tions defined by (A2). Unluckily, the task of generating so-
lutions uniformly out of the polytope is computationally un-
affordable when D becomes larger than a few tens (for typi-
cal genome-scale networks, D can be as large as several hun-
dreds) [9, 10]. For systems like bacteria, however, it is possi-
ble to reduce the complexity of the solution space by coupling
(A2) with the optimization of a (usually linear) score function
representing the biological functionality of the organism in
the selected extracellular conditions (e.g. biomass flux max-
imization under optimal growth conditions for E. coli) [11–
14]. This type of approach provides a further unquestionable
advantage in terms of computational tractability and genome-
scale models of metabolism have been developed along these
lines, for several single-cell organisms.
For cells carrying no clear objective function the latter
approach is much harder to justify and sampling solutions
appears as the most logical step to take. A viable alter-
native to (A2) in such cases consists in relaxing the mass-
balance constraint to allow for a net production of chemical
species, while leaving the network functionally unconstrained
so that the metabolite production profile can be determined
self-consistently. This scenario is described by the system of
inequalities
Sν ≥ 0 , (A3)
which are easily obtained from (A2) if one includes in- and
out-takes in S (and the corresponding fluxes in v). Steady-
state conditions like (A3) were originally introduced by Von
Neumann in the analysis of input-output networks [15] and
simply state that, in non equilibrium steady states, flux con-
figurations in which the network produces a metabolite in ex-
cess of consumption are allowed. In particular, solving (A3)
for ν after fixing a configuration of in-takes (out-takes being
in this case an outcome) allows to retrieve an M -dimensional
vector y = Sν whose entries encode information on whether
metabolite j is being produced (yj > 0) or not (yj = 0) in
that particular solution [16, 17].
The physiological rationale to employ such constraints is
two-fold. On one hand, a net production of certain chemi-
cal species (e.g. amino acids) must be expected to take place
if macromolecular processes outside metabolism strictly de-
fined (e.g. proteinogenesis) are to occur. In absence of an
objective function that accounts for such processes, (A3) ap-
pear as a reasonable minimal constraints for the metabolic
capabilities of a cell, in the sense that they don’t even im-
pose which chemical species are to be globally produced. On
the other hand, when the network reconstruction is incomplete
one should complement (A2) with additional constraints that
account for the flow of chemical species to network modules
not included in the model. Such out-takes may be hard to im-
plement in absence of detailed genomic data. Applying (A3)
to partial network reconstructions allows to deal with this is-
sue rather naturally, by exploring all possible metabolic ex-
changes compatible with the given stoichiometry. Moreover,
its dual problem has recently been given a thermodynamic in-
terpretation in the context of cell metabolism [18, 19].
Appendix B: Numerical analysis: relaxation method
The flux problem (A3) has been studied from a purely the-
oretical perspective in [20–23]. The technical advantage that
accompanies (A3) lies in the existence of a computationally
efficient, statistically controlled method to generate solutions.
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The procedure consists in essence of a Relaxation algorithm
[24] based on the analogy of (A3) with perceptron learning
[25] and is described in detail in [21]. In brief, denoting by
A and B the matrices of input and output stoichiometric in-
dices respectively (so that S = B − A), let ρ > 0 be a real
parameter, let Sρ = B− ρA, and consider the system
Sρν ≥ 0 . (B1)
Given a (generic) flux vector ν (e.g. randomly generated from
a prescribed probability distribution), a solution of (B1) can be
found for any fixed ρ < 1 by the following algorithm:
• compute y = Sρν and j0 = argminj yj (i.e., j0 is the
index of the least satisfied constraint);
• if yj0 ≥ 0 then ν is a solution of (B1); exit.
• if yj0 < 0 then update ν component-wise as
ν → max{0,ν + λS(j0)ρ } (B2)
where λ > 0 is a constant and S(k)ρ is the k-th row of
matrix Sρ; go to 2 and iterate.
This is a classical relaxation procedure. Intuitively, a violated
constraint (yj < 0) signals that the consumption of metabolite
j exceeds its production. The flux of reactions where j par-
ticipates is then modified so as to increase the production flux
and decrease the consumption flux. This procedure converges
to a solution for each ρ < 1 [21] so that the solutions in the
limit ρ → 1, where the original problem is recovered, can be
obtained by increasing ρ recursively to approach 1 with the
desired precision and extrapolating. Notice that the form of
the update step (B2) guarantees that the bounds of variability
0 ≤ νi <∞ are satisfied.
Disposing of large sets of solutions allows to evaluate many
quantities of interest like the statistics of production pro-
files, marginal flux distributions, flux-flux correlations and,
of course, distributions of “macroscopic” observables like, in
our case, the OGI or the CMR (which are defined through
simple functions of the individual fluxes). This approach has
been applied in different contexts to quantify the metabolic
capabilities of cells [26–28]. Following the above procedure,
different solutions can be generated by re-initializing the algo-
rithm from different flux vectors. A crucial question concerns
the statistics of the solution space sampling that can thus be
obtained. This problem has been faced in [19]. In brief, if
one fixes the probability distribution from which initial con-
ditions are generated (‘priors’ for short), repeated iteration of
the above scheme provides a set of solutions that minimize
the average Euclidean distance between the solutions and the
priors. More precisely, let us assume that (for each ρ) initial
conditions are drawn from a fixed, ‘trial’ probability distribu-
tion P0(ν) of flux vectors (for simplicity, one may think that
P0(ν) =
∏N
i=1 P
(i)
0 (νi), with prescribed distributions P
(i)
0 ,
e.g. uniform over a given interval: in this case each initial
vi is selected randomly and independently from its trial dis-
tribution P (i)0 ). Then the solutions ν
? obtained by the above
method are such that the quantity
d2 =
〈
N∑
i=1
(ν?i − νi)2
〉
(B3)
is minimized (the average being taken over P0). In other
words, one obtains a set of solutions that are as close as possi-
ble to the priors used to generate them and the statistical sig-
nificance of the corresponding distributions of fluxes (or other
relevant macroscopic observables like the OGI etc.) can be
interpreted in this light. In essence, multiple (random) initial-
izations of the above algorithm deform the uncorrelated trial
distributions P (i)0 to generate a set of correlated probability
distributions for the νi’s, the correlation being driven by the
form of the reinforcement term. Note that, quite importantly,
the resulting νi’s can exceed the initial bounds defined by P0.
Now it is clear that the solution space picture one obtains
can depend strongly on the choice of the priors. On one hand,
disposing of sufficient empirical information about individ-
ual fluxes one can inject it into the prior (i.e. into P (i)0 , e.g.
by assuming that such distributions are uniform and centered
around the empirical value) to evaluate the extent to which
the solution space is constrained by sampling configurations
“close” (on average) to such a prior. However, in the case we
consider, such an information is not available in the amount
and precision that would be needed. In situations like these it
is reasonable to think that priors should inject into the problem
as little information as possible so as to obtain unbiased in-
formation on the solution space (besides the global constraint
imposed by te minimization of (B3)). This approach has the
advantage of providing a portrait of the solution space that
is minimally constrained by the prior, in the sense that the
emergent features are not due to the external biochemical in-
formation employed but, strictly speaking, to the topology of
the network and the functional constraints (in our case embod-
ied only by the OGI). In this work we have followed such a
prescription.
In summary, we have solved (A3) using the above method
for the (partial) network reconstruction described in following
section. For the trial functions P (i)0 , we took uniform distribu-
tions on [0, 1] (as said above, the initial bounds of variability
allowed for the fluxes can be exceeded by the algorithm). The
only additional constraint imposed on the solution space of
(A3) is given by the uptake of GLC to the capillary, which is
fixed and tuned externally. All other fluxes are computed self-
consistently. This implies that our solution space may contain
unphysiologic states that we do not discount a priori. Our
focus is indeed on exploring a minimally constrained solu-
tion space. Assessing the robustness of the emerging scenario
against physiological data instead highlights which bounds
on variables/constraints should necessarily be added to non-
equilibrium steady state models in order to reproduce a real-
istic phenomenology.
Appendix C: Network reconstruction: details
We reconstruct the cerebral metabolism via a compartmen-
talized model divided into blood capillary (c), extracellular
space (e), neuron (n) and astrocyte (a). The last two compart-
ments are then divided into cytosol (nc and ac respectively)
and mitochondria (nm and am), while we also consider vesi-
cles (nv) in synapses, from where the neurotransmitter gluta-
mate is released to the extracellular medium. Considering the
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reversibility of reactions the network altogether encompasses
139 chemical reactions, reported in table I, which process 108
chemical species, listed in table II. Reaction names are deter-
mined by the catalyzing enzymes or, in the case of transport
processes, by the chemical compound itself. The compart-
ments involved by the chemical processes are also specified,
so that, for example, νHK(n) denotes the reaction catalyzed
by the hexokinase in neurons, while νO2(c → n) indicates
an oxygen transport from the capillary to the neuron. In case
of reversible reactions, the forward and reverse processes are
separated into two different reactions, labeled with f and r
respectively.
Since we are mainly interested in the carbohydrate
metabolism and related energetic production, we specifically
consider pathways involved in those processes plus some
other features peculiar of cerebral cells, like for instance cre-
atine synthesis and metabolism. Apart from oxygen, lactate
and glucose transport from/to the capillary vessel and within
the system, we have considered 14 main paths, which allow
the system to self-sustain itself. We included glycolysis, pen-
tose phosphate pathway, Tricarboxylic acid cycle (TCA), ox-
idative phosphorylation, which are all inherent to carbohy-
drate metabolism. To allow detoxification of species pro-
duced by the latter we then included the Glutathione-ascorbate
(GSH/ASC) cycle, while transport of reducing equivalents
(NADH) is performed through the Malate Aspartate shuttle,
in turn coupled with the pentose phosphate pathway and the
NAD/NADP interconversion. The coupling between func-
tionality and metabolism is assured through neurotransmis-
sion and transmitter recycling, which together with the ionic
movements provides a metabolic interconnection between
neurons and astrocytes.
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TABLE I: List of reactions.
Abbreviation Chemical Reaction
GLC, O2 and LAC Transport
1 νGLC(c) → GLCc
2 νGLC(c→ a) GLCc → GLCa
3 νGLC(c→ e) GLCc → GLCe
4 νGLC(e→ a) GLCe → GLCa
5 νGLC(e→ n) GLCe → GLCn
6 νO2(c) → O2c
7 νO2(c→ a) O2c → O2a
8 νO2(c→ n) O2c → O2n
9 νLAC(c) LACc →
10 νLAC(e→ c) LACe → LACc
11 νLAC(a→ c) LACa → LACc
12 νLAC(e→ a) LACe → LACa
13 νLAC(a→ e) LACa → LACe
14 νLAC(e→ n) LACe → LACn
15 νLAC(n→ e) LACn → LACe
Creatine & Adenylate Kinase Buffers
16 νCKf(n) ATPn +Crn → ADPn + PCrn
17 νCKr(n) ADPn + PCrn → ATPn +Crn
18 νCKf(a) ATPa +Cra → ADPa + PCra
19 νCKr(a) ADPa + PCra → ATPa +Cra
20 νAKf(n) 2 ADPn → AMPn +ATPn
21 νAKr(n) AMPn +ATPn → 2 ADPn
22 νAKf(a) 2 ADPa → AMPa +ATPa
23 νAKr(a) AMPa +ATPa → 2 ADPa
Pentose Phosphate Pathway
24 νPPP(n) 3 G6Pn + 6 NADPn → 2 F6Pn +GAPn + 6 NADPHn
25 νPPP(a) 3 G6Pa + 6 NADPa → 2 F6Pa +GAPa + 6 NADPHa
Ionic movements
26 νNAK(n) ATPn + 2 Ke + 3 Nan → ADPn + 2 Kn + 3 Nae
27 νNAK(a) ATPa + 2 Ke + 3 Naa → ADPa + 2 Ka + 3 Nae
28 νNKCC(a) Ke +Nae → Ka +Naa
29 νNa(n) Nae → Nan
30 νK(n) Kn → Ke
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TABLE I: List of reactions.
Abbreviation Chemical Reaction
GSH/ASC Cycle (metabolism and transport)
31 νGR1(n) GSSGn +NADPHn → GSHn +NADPn
32 νGR2(n) GSSGn +NADPHnm → GSHn +NADPnm
33 νDHAR(n) DHAn +GSHn → ASCn +GSSGn
34 νAPX(n) ASCn +ROSn → DHAn
35 νGR1(a) GSSGa +NADPHa → GSHa +NADPa
36 νGR2(a) GSSGa +NADPHam → GSHa +NADPam
37 νDHAR(a) DHAa +GSHa → ASCa +GSSGa
38 νAPX(a) ASCa +ROSa → DHAa
39 νGSH(a) → GSHa
40 νGSH(a→ e) GSHa → GSHe
41 νGSH(e→ n) GSHe → GSHn
42 νDHA(n→ e) DHAn → DHAe
43 νDHA(e→ n) DHAe → DHAn
44 νDHA(e→ a) DHAe → DHAa
45 νDHA(a→ e) DHAa → DHAe
46 νASC(a→ e) ASCa → ASCe
47 νASC(e→ a) ASCe → ASCa
48 νASC(e→ n) ASCe + 2 Nae → ASCn + 2 Nan
Neurotransmission and GLU/GLN Cycle
49 νGLU(e→ a) GLUe +Ka + 3 Nae → GLUac +Ke + 3 Naa
50 νGS(a) ATPa +GLUac → ADPa +GLNa
51 νGLN(a→ n) GLNa → GLNn
52 νPAG(n) GLNn → GLUnc
53 νGLU(n) ATPn +GLUnc → ADPn +GLUnv
54 νNT(n→ e) GLUnv→ GLUe
Glycolysis and Glycogenolysis
55 νHK(n) ATPn +GLCn → ADPn +G6Pn
56 νPFK(n) ATPn +G6Pn → ADPn + 2 GAPn
57 νGAPDHf(n) GAPn +NADnc → BPGn +NADHnc
58 νGAPDHr(n) BPGn +NADHnc → GAPn +NADnc
59 νPGKf(n) ADPn +BPGn → ATPn + PEPn
60 νPGKr(n) ATPn + PEPn → ADPn +BPGn
61 νPK(n) ADPn + PEPn → ATPn + PYRnc
62 νLDHf(n) NADHnc + PYRnc → LACn +NADnc
63 νLDHr(n) LACn +NADnc → NADHnc + PYRnc
64 νHK(a) ATPa +GLCa → ADPa +G6Pa
65 νPFK(a) ATPa +G6Pa → ADPa + 2 GAPa
66 νGAPDHf(a) GAPa +NADac → BPGa +NADHac
67 νGAPDHr(a) BPGa +NADHac → GAPa +NADac
68 νPGKf(a) ADPa +BPGa → ATPa + PEPa
69 νPGKr(a) ATPa + PEPa → ADPa +BPGa
70 νPK(a) ADPa + PEPa → ATPa + PYRac
71 νLDHf(a) NADHac + PYRac → LACa +NADac
72 νLDHr(a) LACa +NADac → NADHac + PYRac
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TABLE I: List of reactions.
Abbreviation Chemical Reaction
Pyruvate Shuttling to Mitochondria
73 νPYRf(n) PYRnc → PYRnm
74 νPYRr(n) PYRnm → PYRnc
75 νPYRf(a) PYRac → PYRam
76 νPYRr(a) PYRam → PYRac
Oxidative Phosphorylation
77 νOP(n) 5 ADPn + 2 NADHnm +O2n → 5 ATPn + 2 NADnm + 0.01 ROSn
78 νOP(a) 5 ADPa + 2 NADHam +O2a → 5 ATPa + 2 NADam + 0.01 ROSa
NAD/NADP Interconversion
79 νNAD(n) NADHnm +NADPnm → NADPHnm +NADnm
80 νNAD(a) NADHam +NADPam → NADPHam +NADam
Anaplerosys
81 νPC(a) ATPa + PYRam → ADPa +OAAam
82 νcME(n) MALnc +NADPn → NADPHnc + PYRnc
83 νmME(n) MALnm +NADPnm → NADPHnm + PYRnm
84 νcME(a) MALac +NADPa → NADPHac + PYRac
85 νmME(a) MALam +NADPam → NADPHam + PYRam
TCA Cycle
86 νPDH(n) CoAn +NADnm + PYRnm → ACoAn +NADHnm
87 νCS(n) ACoAn +OAAnm → CITn +CoAn
88 νIDH1(n) CITn +NADnm → AKGnm +NADHnm
89 νIDH2(n) CITn +NADPnm → AKGnm +NADPHnm
90 νIDH3(n) CITn +NADPn → AKGnc +NADPHn
91 νAKGDH(n) AKGnm +CoAn +NADnm → NADHnm + SCoAn
92 νSCoATKf(n) ADPn + SCoAn → ATPn + SUCn
93 νSCoATKr(n) ATPn + SUCn → ADPn + SCoAn
94 νSDHf(n) 1.50 ADPn + 0.10 O2n + 3 SUCn → 1.50 ATPn + 3 FUMn
95 νSDHr(n) 1.50 ATPn + 3 FUMn → 1.50 ADPn + 0.10 O2n + 3 SUCn
96 νFUMf(n) FUMn → MALnm
97 νFUMr(n) MALnm → FUMn
98 νmMDH(n) MALnm +NADnm → NADHnm +OAAnm
99 νPDH(a) CoAa +NADam + PYRam → ACoAa +NADHam
100 νCS(a) ACoAa +OAAam → CITa +CoAa
101 νIDH1(a) CITa +NADam → AKGam +NADHam
102 νIDH2(a) CITa +NADPam → AKGam +NADPHam
103 νIDH3(a) CITa +NADPa → AKGac +NADPHa
104 νAKGDH(a) AKGam +CoAa +NADam → NADHam + SCoAa
105 νSCoATKf(a) ADPa + SCoAa → ATPa + SUCa
106 νSCoATKr(a) ATPa + SUCa → ADPa + SCoAa
107 νSDHf(a) 1.50 ADPa + 0.10 O2a + 3 SUCa → 1.50 ATPa + 3 FUMa
108 νSDHr(a) 1.50 ATPa + 3 FUMa → 1.50 ADPa + 0.10 O2a + 3 SUCa
109 νFUMf(a) FUMa → MALam
110 νFUMr(a) MALam → FUMa
111 νmMDH(a) MALam +NADam → NADHam +OAAam
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TABLE I: List of reactions.
Abbreviation Chemical Reaction
Glycerol 3-P Shuttle
112 νG3PS(n) 1.50 ADPn + 3 NADHnc + 0.10 O2n → 1.50 ATPn + 3 NADnc
113 νG3PS(a) 1.50 ADPa + 3 NADHac + 0.10 O2a → 1.50 ATPa + 3 NADac
MAS
114 νcMDH(n) NADHnc +OAAnc → MALnc +NADnc
115 νOGC(n) AKGnm +MALnc → AKGnc +MALnm
116 νAGC(n) ASPnm +GLUnc → ASPnc +GLUnm
117 νcMDH(a) NADHac +OAAac → MALac +NADac
118 νOGC(a) AKGam +MALac → AKGac +MALam
119 νAGC(a) ASPam +GLUac → ASPac +GLUam
Aspartate Metabolism and Shuttling
120 νcAATf(n) AKGnc +ASPnc → GLUnc +OAAnc
121 νcAATr(n) GLUnc +OAAnc → AKGnc +ASPnc
122 νmAATf(n) AKGnm +ASPnm → GLUnm +OAAnm
123 νmAATr(n) GLUnm +OAAnm → AKGnm +ASPnm
124 νcAATf(a) AKGac +ASPac → GLUac +OAAac
125 νcAATr(a) GLUac +OAAac → AKGac +ASPac
126 νmAATf(a) AKGam +ASPam → GLUam +OAAam
127 νmAATr(a) GLUam +OAAam → AKGam +ASPam
128 νASPf(n→ a) ASPnc → ASPac
129 νASPr(n→ a) ASPac → ASPnc
130 νASPf(n) ASPnc → ASPnm
131 νASPr(n) ASPnm → ASPnc
132 νASPf(a) ASPac → ASPam
133 νASPr(a) ASPam → ASPac
Glutamate Metabolism
134 νGDHf(n) GLUnm +NADPnm → AKGnm +NADPHnm
135 νGDHr(n) AKGnm +NADPHnm → GLUnm +NADPnm
136 νGDHf(a) GLUam +NADPam → AKGam +NADPHam
137 νGDHr(a) AKGam +NADPHam → GLUam +NADPam
Housekeeping
138 νATP(n) ATPn → ADPn
139 νATP(a) ATPa → ADPa
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TABLE II: List of metabolites.
No. Abbr. Name No. Abbr. Name
Neuron
1 ACoAn Acetyl-CoA 26 Kn Potassium
2 ADPn Adenosine diphosphate 27 LACn Lactic acid
3 AKGnc α-Ketoglutaric acid 28 MALnc Malic acid
4 AKGnm α-Ketoglutaric acid (m) 29 MALnm Malic acid (m)
5 AMPn Adenosine monophosphate 30 NADHnc N. adenine dinucleotide
6 ASCn Ascorbic acid 31 NADHnm N. adenine dinucleotide (m)
7 ASPnc Aspartic acid 32 NADnc N. adenine dinucleotide
8 ASPnm Aspartic acid (m) 33 NADnm N. adenine dinucleotide (m)
9 ATPn Adenosine triphosphate 34 NADPHn N. adenine dinucleotideph.
10 BPGn 1,3-Bisphosphoglyceric acid 35 NADPHnc N. adenine dinucleotideph.
11 CITn Citrate 36 NADPHnm N. adenine dinucleotideph.(m)
12 CoAn Coenzyme A 37 NADPn N. adenine dinucleotideph.
13 Crn Creatine 38 NADPnm N. adenine dinucleotideph.(m)
14 DHAn Dehydroascorbic acid 39 Nan Sodium
15 F6Pn Fructose 6-phosphate 40 O2n Oxygen
16 FUMn Fumaric acid 41 OAAnc Oxaloacetic acid
17 G6Pn Glucose 6-phosphate 42 OAAnm Oxaloacetic acid
18 GAPn Glyceraldehyde 3-phosphate 43 PCrn Phosphocreatine
19 GLCn Glucose 44 PEPn Phosphoenolpyruvic acid
20 GLNn Glutamine 45 PYRnc Pyruvic acid
21 GLUnc Glutamate 46 PYRnm Pyruvic acid (m)
22 GLUnm Glutamate (m) 47 ROSn Reactive oxygen species
23 GLUnv Glutamate (vescicle) 48 SCoAn Succinyl-CoA
24 GSHn Glutathione 49 SUCn Succinic acid
25 GSSGn Glutathione disulfide
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TABLE II: List of metabolites.
No. Abbr. Name No. Abbr. Name
Astrocyte
50 ACoAa Acetyl-CoA 74 Ka Potassium
51 ADPa denosine diphosphate 75 LACa Lactic acid
52 AKGac α-Ketoglutaric acid 76 MALac Malic acid
53 AKGam α-Ketoglutaric acid (m) 77 MALam Malic acid (m)
54 AMPa Adenosine monophosphate 78 Naa Sodium
55 ASCa Ascorbic acid 79 NADac N. adenine dinucleotide
56 ASPac Aspartic acid 80 NADam N. adenine dinucleotide (m)
57 ASPam Aspartic acid (m) 81 NADHac N. adenine dinucleotide
58 ATPa Adenosine triphosphate 82 NADHam N. adenine dinucleotide (m)
59 BPGa 1,3-Bisphosphoglyceric acid 83 NADPa N. adenine dinucleotideph.
60 CITa Citrate 84 NADPam N. adenine dinucleotideph. (m)
61 CoAa Coenzyme A 85 NADPHa N. adenine dinucleotideph.
62 Cra Creatine 86 NADPHac N. adenine dinucleotideph.
63 DHAa Dehydroascorbic acid 87 NADPHam N. adenine dinucleotideph. (m)
64 F6Pa Fructose 6-phosphate 88 O2a Oxygen
65 FUMa Fumaric acid 89 OAAac Oxaloacetic acid
66 G6Pa Glucose 6-phosphate 90 OAAam Oxaloacetic acid (m)
67 GAPa Glyceraldehyde 3-phosphate 91 PCra Phosphocreatine
68 GLCa Glucose 92 PEPa Phosphoenolpyruvic acid
69 GLNa Glutamine 93 PYRac Pyruvic acid
70 GLUac Glutamate 94 PYRam Pyruvic acid (m)
71 GLUam Glutamate (m) 95 ROSa Reactive oxygen species
72 GSHa Glutathione 96 SCoAa Succinyl-CoA
73 GSSGa Glutathione disulfide 97 SUCa Succinic acid
Extracellular space and blood capillary
98 ASCe Ascorbic acid 104 LACe Lactic acid
99 DHAe Dehydroascorbic acid 105 Nae Sodium
100 GLCe Glucose 106 GLCc Glucose
101 GLUe Glutamate 107 LACc Lactic acid
102 GSHe Glutathione 108 O2c Oxygen
103 Ke Potassium
